Botulinum toxin for prevention of post-operative atrial fibrillation

Naunyn Schmiedebergs Arch Pharmacol. 2023 Mar;396(3):385-388. doi: 10.1007/s00210-023-02402-y.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atrial Fibrillation* / drug therapy
  • Atrial Fibrillation* / prevention & control
  • Botulinum Toxins* / therapeutic use
  • Humans
  • Postoperative Complications / prevention & control

Substances

  • Botulinum Toxins